AWK:NYSEAmerican Water Works Company, Inc. Analysis
Data as of 2026-06-21 - not real-time
$125.07
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
American Water Works (AWK) trades around $125, comfortably above its 20‑day SMA and below both its 50‑day and 200‑day SMAs, signaling a bearish bias in the short‑term price action. The RSI sits near the midpoint at 48, while the MACD histogram is positive despite a bearish overall trend, suggesting limited upside momentum.
Fundamentally, the company posted 5.7% revenue growth, an operating margin above 30%, and reaffirmed its full‑year EPS guidance, while maintaining a 7‑9% dividend growth outlook and an 8% quarterly dividend increase. The recent $185 million PFAS settlement and pending rate cases in five jurisdictions provide a potential earnings tailwind, but a high debt‑to‑equity ratio and negative free cash flow temper the outlook.
Fundamentally, the company posted 5.7% revenue growth, an operating margin above 30%, and reaffirmed its full‑year EPS guidance, while maintaining a 7‑9% dividend growth outlook and an 8% quarterly dividend increase. The recent $185 million PFAS settlement and pending rate cases in five jurisdictions provide a potential earnings tailwind, but a high debt‑to‑equity ratio and negative free cash flow temper the outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near recent support level and below key moving averages
- Bearish technical momentum despite a modest MACD histogram
- Attractive dividend yield offsetting short‑term downside risk
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Confirmed EPS guidance and 7‑9% dividend growth plan
- Potential rate‑case earnings uplift in key states
- High leverage and negative free cash flow requiring monitoring
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Secular demand for water services and regulated revenue base
- Consistent dividend increases supported by rate case outcomes
- Long‑term cash‑flow visibility despite current debt load
Key Metrics & Analysis
Financial Health
Revenue Growth5.70%
Profit Margin21.17%
P/E Ratio22.2
ROE10.22%
ROA3.51%
Debt/Equity142.33
P/B Ratio2.2
Op. Cash Flow$2.0B
Free Cash Flow$-1896625024
Industry P/E20.6
Technical Analysis
TrendBearish
RSI48.5
Support$120.57
Resistance$128.74
MA 20$124.44
MA 50$127.49
MA 200$132.16
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair Value$42.92
Target Price$135.55
Upside/Downside8.38%
GradeOvervalued
TypeBlend
Dividend Yield2.86%
Risk Assessment
Beta-0.42
Volatility20.53%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.